XML 49 R28.htm IDEA: XBRL DOCUMENT v3.23.2
INCOME TAXES
12 Months Ended
Jan. 31, 2023
Jan. 31, 2021
Income Tax Disclosure [Abstract]    
INCOME TAXES [Text Block]

21. INCOME TAXES

The Company is a Canadian resident company, as defined in the Income Tax Act (Canada) (the "ITA"), for Canadian income tax purposes. However, it has subsidiaries that are treated as United States corporations for US federal income tax purposes per the Internal Revenue Code (US) ("IRC") and are thereby subject to federal income tax on their worldwide income. As a result, the Company is subject to taxation both in Canada and the United States.

A summary of the Company's components of the income tax provision for the years ended January 31, 2023 and 2022, is as follows:

    2023     2022
(As restated - 
Note 2)
 
  $     $    
Current            
Canadian   -     -  
US Federal and State   2,866,688     4,344,395  
Total current income tax expense   2,866,688     4,344,395  
             
Deferred            
Canadian   -     -  
US Federal and State   (56,920 )   590,072  
Total deferred income tax recovery   (56,920 )   590,072  
             
Total income tax expense   2,809,768     4,934,467  

A summary of the Company's domestic and foreign components of income (loss) before provision for income taxes for the years ended January 31, 2023 and 2022, is as follows:

    2023     2022
(As restated - 
Note 2)
 
    $     $  
Canadian   (702,488 )   6,985,670  
United States   4,893,796     10,146,371  
Income (loss) before income taxes   4,191,308     17,132,041  

A summary of the Company's reconciliation of the statutory income tax rate percentage to the effective tax rate for the years ended January 31, 2023 and 2022 is as follows:

    2023     2022
(As restated -
Note 2)
 
    $     $  
Income (loss) for the year   4,191,308     17,132,041  
Statutory rate   27%     27%  
             
Income tax expense at statutory rate   1,131,653     4,625,653  
Non-deductible expenditures and non-taxable revenues            
IRC section 280E disallowance   1,802,992     1,834,479  
Other   56,549     98,946  
Foreign tax rate differential   (288,933 )   (608,783 )
Change in foreign exchange rates and other   196,298     115,835  
Change in valuation allowance   (198,848 )   (73,893 )
Payable adjustment to provision versus statutory tax returns   67,056     2,738,188  
Deferred adjustment to provision versus statutory tax returns   10,410     (4,316,443 )
Uncertain tax position, inclusive of interest and penalties   32,591     520,485  
    2,809,768     4,934,467  

 

A summary of the Company's deferred tax assets significant components is as follows:

    January 31,
2023
    January 31,
2022
(As restated -
Note 2)
 
    $     $  
Deferred tax assets            
Share issuance costs and financing fees   4,764     262,726  
Allowable capital losses   132,986     139,182  
Non-capital losses   4,699,606     4,376,843  
Intangible assets   85,843     98,394  
Right of use assets and lease liabilities, net   73,247     53,248  
Reclamation obligation   14,219     14,923  
Derivative liability   64,719     271,719  
Inventories   36,797     -  
Convertible promissory note   312,190     345,989  
Total deferred tax assets   5,424,371     5,563,024  
Valuation allowance   (5,311,368)     (5,510,216)  
Total net deferred tax assets   113,003     52,808  
             
Deferred tax liabilities            
Property and equipment   (89,641)     (86,366)  
Net deferred tax (liability) asset   23,362     (33,558)  

Realization of deferred tax assets associated with the net operating loss carryforwards is dependent upon generating sufficient taxable income prior to their expiration. A valuation allowance to reflect management's estimate of the Canadian loss carryforwards that may expire prior to their utilization has been recorded at January 31, 2023.

As of January 31, 2023, the Company has $17.4 million of Canadian non-capital loses which expire between 2026 and 2043, and Canadian capital losses of $985 thousand with no expiry date. The Company determined a valuation allowance was also applicable to the other Canadian deferred tax assets. The Company also has of $2.7 million of Oregon net operating losses which have a 15-year carryforward period with losses expiring between 2034 and 2038. The Company determined a valuation allowance was applicable to the full amount of the available Canadian losses.

As the Company operates in the cannabis industry, the Company is subject to the limits of Internal Revenue Code ("IRC") Section 280E for US federal income tax purposes as well as state income tax purposes. Under IRC Section 280E, the Company is only allowed to deduct expenses directly related to costs of goods sold. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E.

Management assesses the available positive and negative evidence to estimate whether sufficient future taxable income will be generated to permit use of the existing deferred tax assets. A significant piece of objective negative evidence evaluated was the cumulative loss incurred by the Canadian entity over the three-year period ended January 31, 2023. Such objective evidence limits the ability to consider other subjective evidence, such as our projections for future growth.

On the basis of this evaluation, as of January 31, 2023, a valuation allowance of $5,311,368 (2022 - $5,510,216) has been recorded to recognize only the portion of the deferred tax asset that is more likely than not to be realized. The amount of the deferred tax asset considered realizable, however, could be adjusted if estimates of future taxable income during the carryforward period are reduced or increased or if objective negative evidence in the form of cumulative losses is no longer present and additional weight is given to subjective evidence such as our projections for growth.

The Company recognizes benefits from uncertain tax positions based on the cumulative probability method whereby the largest benefit with a cumulative probability of greater than 50% is recorded. An uncertain tax position is not recognized if it has less than a 50% likelihood of being sustained. As of January 31, 2023, and January 31, 2022, the Company recorded an uncertain tax liability of $846,446 and $813,855, respectively, inclusive of interest and penalties.

The uncertain tax position comprises of certain deductions for lease obligations, depreciation and amortization taken in prior years in excess of the accounting expenses in respect of assets used in production as well as deductions for inventory impairment that were not previously taken. The total of these uncertainties before interest and penalties is $789,112 as of January 31, 2023. The Company believes it is reasonably possible that $401,824 of unrecognized tax benefits related to depreciation and $7,745 of unrecognized tax benefits related to amortization, lease obligations and inventory may decrease within the next 12 months as the Company will be filing amended tax returns for prior years and amounts will be coming statute-barred with respect to the 2020 fiscal year.

During the years ended January 31, 2023, the Company recorded interest of $55,065 and penalties of $2,268 on uncertain tax liabilities within the consolidated statements of operations and comprehensive (loss) income. The Company is subject to taxation and files income tax returns in Canada, the U.S. and Oregon. As of January 31, 2023, the tax returns for the 2020, 2021 and 2022 fiscal years are subject to examination by tax authorities in the U.S. and Oregon. The tax return for the 2019 fiscal year is also subject to examination by tax authorities in Canada.

The aggregate change in the balance of gross unrecognized tax benefits, which includes interest and penalties is as follows:

    January 31,
2023
    2022
(As restated -
Note 2)
 
    $     $  
Beginning balance   813,855     293,370  
Increase due to tax positions taken during a prior year   32,591     520,485  
Ending balance   846,446     813,855  

The total amount of unrecognized tax benefits that would, if recognized, impact the effective tax rate is $846,446 for the tax year ended January 31, 2023 ($813,855 for January 31, 2022).

A summary of the components of the Company's income taxes payable is as follows:

    January 31,
2023
    January 31,
2022
(As restated -
Note 2)
 
    $     $  
Income taxes payable   6,890,412     4,056,315  
Unrecognized tax position, inclusive of interest and penalties   846,446     813,855  
    7,736,858     4,870,170  

19. INCOME TAXES

The Company is a Canadian resident company, as defined in the Income Tax Act (Canada) (the "ITA"), for Canadian income tax purposes. However, it has subsidiaries that are treated as United States corporations for US federal income tax purposes per the Internal Revenue Code (US) ("IRC") and are thereby subject to federal income tax on their worldwide income. As a result, the Company is subject to taxation both in Canada and the United States.

The components of the income tax provision for the year ended January 31, 2021 include:

   

January 31,

2021

 
    $  
Current      
Canadian   -  
US Federal   2,366,046  
Total current income tax expense   2,366,046  
       
Deferred      
Canadian   -  
US Federal   602,087  
Total deferred income tax recovery   602,087  
       
Total income tax expense   2,968,133  
 

The domestic and foreign components of loss before provision for income taxes consisted of the following:

   

January 31,
2021

 
    $  
Canadian   (11,678,406 )
US Federal   10,044,967  
Loss before income taxes   (1,633,439 )

A reconciliation of the statutory income tax rate percentage to the effective tax rate for the year ended January 31, 2021 is as follows:

   

January 31,
2021

 
    $  
Loss for the year   (1,633,439 )
Statutory rate   27%  
       
Income tax recovery at statutory rate   (441,029 )
Non-deductible expenditures and non-taxable revenues   1,842,777  
Foreign tax rate differential   (602,698 )
Change in valuation allowance   737,667  
Adjustment to provision versus statutory tax returns   1,431,416  
    2,968,133  

The significant components of the Company's deferred tax assets as follows at January 31, 2021:

   

January 31,
2021

 
    $  
Deferred tax assets      
Share issuance costs and financing fees   505,035  
Allowable capital losses   138,421  
Non-capital losses   3,834,262  
Intangible assets   816,736  
Mineral resource properties   983,977  
Right of use assets and lease liabilities, net   63,032  
Goodwill   -  
Reclamation obligation   14,852  
Total deferred tax assets   6,356,315  
Valuation allowance   (5,573,835 )
Total net deferred tax assets   782,480  
       
Deferred tax liabilities      
Property and equipment   (225,966 )
Net deferred tax asset   556,514  
 

Realization of deferred tax assets associated with the net operating loss carryforwards is dependent upon generating sufficient taxable income prior to their expiration. A valuation allowance to reflect management's estimate of the net operating loss carryforwards that may expire prior to their utilization has been recorded at January 31, 2021.

As the Company operates in the cannabis industry, the Company is subject to the limits of Internal Revenue Code ("IRC") Section 280E for US federal income tax purposes as well as state income tax purposes for all states except for California and Colorado. Under IRC Section 280E, the Company is only allowed to deduct expenses directly related to costs of goods sold. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E.

Management assesses the available positive and negative evidence to estimate whether sufficient future taxable income will be generated to permit use of the existing deferred tax assets. A significant piece of objective negative evidence evaluated was the cumulative loss incurred by the Canadian entity over the three-year period ended January 31, 2021. Such objective evidence limits the ability to consider other subjective evidence, such as our projections for future growth.

On the basis of this evaluation, as of January 31, 2021, a valuation allowance of $5,573,835 has been recorded to recognize only the portion of the deferred tax asset that is more likely than not to be realized. The amount of the deferred tax asset considered realizable, however, could be adjusted if estimates of future taxable income during the carryforward period are reduced or increased or if objective negative evidence in the form of cumulative losses is no longer present and additional weight is given to subjective evidence such as our projections for growth.

The Company recognizes benefits from uncertain tax positions based on the cumulative probability method whereby the largest benefit with a cumulative probability of greater than 50% is recorded. An uncertain tax position is not recognized if it has less than a 50% likelihood of being sustained. As of January 31, 2021, the Company has not recorded any uncertain tax assets or liabilities.

The Company does not expect that uncertain tax benefits will materially change in the next 12 months. The Company is subject to taxation in Canada and the United States. As of January 31, 2021, tax years for 2019 and 2020 are subject to examination by the tax authorities. The 2018 tax year is also subject to investigation in Canada.